Asahi Intecc Co., Ltd. 7747
TSE · Japan · Health Technology
¥3,365.00+40.00 (+1.20%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Asahi Intecc (TSE:7747) has drawn fresh attention after its recent share performance, with the price closing at ¥3,330. Investors now have clearer context for weighing the stock’s value score of 1. Recent trading has been choppy for Asahi Intecc, with the share price up 1.99% over the last day and 1.68% over the past week, but down 12.60% over 30 days and 10.82% over 90 days. Even with that fading short term momentum, longer term performance remains far stronger, with a 12.20% year to date...
Asahi Intecc USA, a global leader in medical device technologies, proudly announces its official entry into the gastrointestinal (GI) market in the United States. Marking this strategic milestone, Asahi introduces two innovative endoscopic tools: Tornus ES (Endoscopic Dilator) and Fielder 18 (Endoscopic Guidewire). These devices represent the company's first step into the GI field, bringing its proven track record in cardiovascular and neurovascular interventions to support gastroenterologists h
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.